Abstract:The COVID-19 outbreak has caused significant global changes and increased public awareness of SARS-CoV-2. Substantial progress in developing vaccines, enhancing sanitation practices, and implementing various measures to combat the virus, including the utilization of probiotics has been made. This comprehensive review examined the medical impact of clinically proven probiotics on infectious diseases, considering three crucial time periods: before (pre-), during (mid-), and after (post-) COVID-19 pandemic era. This review also showed a perspective on the use of probiotics to stimulate the innate immune system and prevent infectious diseases. In pre-COVID-19 era, several probiotic strains were found to be clinically effective in addressing gastrointestinal infectious diseases, the common cold and flu. However, the mechanism by which probiotics exerted their antiviral effects remained relatively unclear during that period. Nevertheless, probiotics, Lactococcus lactis strain Plasma (LC-Plasma), and others have gained attention for their unique ability to modulate the immune system and demonstrate antiviral properties. While some probiotics have shown promise in alleviating gastrointestinal symptoms linked to COVID-19, their direct effectiveness in treating or preventing COVID-19 progression has not yet been conclusively established. As we transition into the post-COVID-19 era, the relationship between COVID-19 and plasmacytoid dendritic cells (pDCs), a vital component of the innate immune system, has been gradually elucidated. These findings are now being applied in developing novel vaccines and treatments involving interferons and in immune activation research using probiotics as adjuvants, comparable to CpG-DNA through TLR9. The role of the local innate immune system, including pDCs, as the first line of defense against viral infections has gained increasing interest. Moving forward, insight of the immune system and the crosstalk between probiotics and the innate immune system is expected to highlight the role of probiotics in adjunctive immunoregulatory therapy. In combination with drug treatments, probiotics may play a more substantial role in enhancing immune responses. The immunoregulatory approach using probiotics such as LC-Plasma, which can induce anti-infectious factors such as interferons, holds promise as a viable therapeutic and prophylactic option against viral infectious diseases due to their good safety profile and protective efficacy.

Modulation of gut microbiota protects against viral respiratory tract infections: a systematic review of animal and clinical studies

Do Probiotics Help Prevent Ventilator-Associated Pneumonia In Critically Ill Patients? A Systematic Review With Meta-Analysis

Probiotics for immunomodulation in prevention against respiratory viral infections with special emphasis on COVID-19

Intestinal Microbiota—A Promising Target for Antiviral Therapy?

The Modulation of Mucosal Antiviral Immunity by Immunobiotics: Could They Offer Any Benefit in the SARS-CoV-2 Pandemic?

Prophylactic effects of probiotics on respiratory viruses including COVID-19: a review

Probiotics Confers Protection Against RSV Infections by Regulating Gut and Lung Microbiotas to Activate Antiviral Responses of Alveolar Macrophage

Probiotics reduce self-reported symptoms of upper respiratory tract infection in overweight and obese adults: should we be considering probiotics during viral pandemics?

Probiotics protect against RSV infection by modulating the microbiota-alveolar-macrophage axis

Modulated Gut Microbiota for Potential COVID-19 Prevention and Treatment

An analysis of microbiota-targeted therapies in patients with avian influenza virus subtype H7N9 infection

Potential probiotics for regulation of the gut-lung axis to prevent or alleviate influenza in vulnerable populations

Dual and mutual interaction between microbiota and viral infections: a possible treat for COVID-19

Overview of anti-viral effects of probiotics via immune cells in pre-, mid- and post-SARS-CoV2 era

Effect of probiotics as an immune modulator for the management of COVID-19

The Potential Role of Probiotics in Protection against Influenza a Virus Infection in Mice

Probiotic-Based Bacteriocin: Immunity Supplementation Against Viruses. An Updated Review

The Effect of Probiotic Treatment on Patients Infected with the H7N9 Influenza Virus.

Modulation of Respiratory TLR3-Anti-Viral Response by Probiotic Microorganisms: Lessons Learned from Lactobacillus rhamnosus CRL1505

Role of the intestinal microbiota in host defense against respiratory viral infections

Probiotics in treatment of respiratory viral infections